What's new

RSS
Date Content
14/12/2018 EudraVigilance access policy for medicines for veterinary use
14/12/2018 European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH) , European Medicines Agency, London, UK, from 03/12/2018 to 03/12/2018 (updated)
14/12/2018 Other: Decision on rules relating to Articles 11, 11a and 13 of the Staff Regulations concerning the handling of declared interests of staff members of the European Medicines Agency and candidates before recruitment (updated)
14/12/2018 Agenda: Agenda for the 102nd meeting of the Management Board (updated)
14/12/2018 Summary of opinion: Adcetris, brentuximab vedotin, 13/12/2018, Positive
14/12/2018 Summary of opinion: Trecondi, treosulfan, 13/12/2018, Positive
14/12/2018 Summary of opinion: Lusutrombopag Shionogi, lusutrombopag, 13/12/2018, Positive
14/12/2018 Summary of opinion: Besremi, ropeginterferon alfa-2b, 13/12/2018, Positive
14/12/2018 Summary of opinion: Rapiscan, regadenoson, 13/12/2018, Positive
14/12/2018 Referral: Fosfomycin-containing medicinal products , fosfomycin calcium, fosfomycin disodium, fosfomycin sodium, fosfomycin trometamol , Article 31 referrals, Procedure started, 13/12/2018